<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00996294</url>
  </required_header>
  <id_info>
    <org_study_id>DIA-CHIR</org_study_id>
    <nct_id>NCT00996294</nct_id>
  </id_info>
  <brief_title>Surgical Treatment of Type 2 Diabetes Mellitus in &lt;35 Body Mass Index (BMI)</brief_title>
  <official_title>Surgical Treatment of Type 2 Diabetes Mellitus in Patients With BMI &lt;35 kg/m2 (Italian Title: &quot;La Terapia Chirurgica Del Diabete Mellito di Tipo 2 Nel Paziente Con BMI Inferiore a 35 kg/m2&quot;)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thirty type 2 diabetic patients will be submitted to biliopancreatic diversion and 20 to
      gastric bypass. Subjects will be monitored during a 5 year period to assess the effects of
      the operations on diabetes control.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2007</start_date>
  <completion_date type="Anticipated">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diabetes control, define by FSG and HbA1c</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes control defined by FSG and HbA1c</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Bariatric Surgery</condition>
  <condition>Biliopancreatic Diversion</condition>
  <condition>Gastric Bypass</condition>
  <arm_group>
    <arm_group_label>surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will be submitted to biliopancreatic diversion or gastric bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>biliopancreatic diversion, gastric bypass</intervention_name>
    <description>biliopancreatic diversion consists of a distal gastrectomy with a long Roux-en-Y reconstruction, where the enteroenterostomy is placed 50 cm proximal to the ileocecal valve gastric bypass consists of creating a small proximal gastric pouch by division of the upper stomach, with reconstruction of the GI continuity by means of a Roux-en-Y loop</description>
    <arm_group_label>surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes mellitus

          -  Duration of diabetes ≥ 3 years

          -  Poor glycemic control (i.e., HbA1c ≥ 7.5%) in spite of hypoglycemic therapy in
             accordance with good clinical practice (GCP)

        Exclusion Criteria:

          -  Specific contraindication to obesity surgery or biliopancreatic diversion or gastric
             bypass

          -  Pregnancy

          -  Medical conditions requiring acute hospitalisation

          -  Severe diabetes complications or associated medical conditions [such as blindness,
             end-stage renal failure (i.e. serum creatinine &gt;2 mg/dl), liver cirrhosis, malignancy,
             chronic congestive heart failure (NYHA class III and IV)]

          -  Recent (within preceding 12 months) myocardial infarction, stroke or TIA

          -  Unstable angina pectoris

          -  Psychological conditions which may hamper patient's cooperation

          -  Geographic inaccessibility

          -  Any condition which, in the judgment of the Investigator, may make risky the
             participation in the study or bias the results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicola Scopinaro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera Universitaria &quot;San Martino&quot;, Genova, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale San Martino</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2009</study_first_submitted>
  <study_first_submitted_qc>October 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2009</study_first_posted>
  <last_update_submitted>January 11, 2010</last_update_submitted>
  <last_update_submitted_qc>January 11, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2010</last_update_posted>
  <responsible_party>
    <name_title>Nicola Scopinaro</name_title>
    <organization>Azienda Ospedaliera Universitaria &quot;San Martino&quot;, Genova, Italy</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

